Complement Factor H Polymorphism in Age-Related Macular Degeneration

Ophthalmology

Volumn 114, Issue 7, 2007, Pages 1327-1331

  Narayanan, Raja ^a,b   Butani, Virit ^a   Boyer, David S ^c   Atilano, Shari R ^a   Resende, Gilberto P ^a   Kim, David S ^a   Chakrabarti, Subhabrata ^b   Kuppermann, Baruch D ^a   Khatibi, Nikan ^d   Chwa, Marilyn ^a   Nesburn, Anthony B ^a,e   Kenney, M Cristina ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b L V PRASAD EYE INSTITUTE   (India)

^c RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; HISTIDINE; TYROSINE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DNA ISOLATION; FEMALE; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; INCIDENCE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETINA MACULA AGE RELATED DEGENERATION;

AGED; AGED, 80 AND OVER; COMPLEMENT FACTOR H; CROSS-SECTIONAL STUDIES; CYTOSINE; GENE FREQUENCY; GENOTYPE; HISTIDINE; HOMOZYGOTE; HUMANS; MACULAR DEGENERATION; MIDDLE AGED; POLYMORPHISM, GENETIC; THYMINE; TYROSINE;

EID: 34347244210     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.10.035     Document Type: Article

References (26)

1. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
2. Edwards A.O., Ritter III R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
3. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
4. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
5. Conley Y.P., Thalamuthu A., Jakobsdottir J., et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet 14 (2005) 1991-2002
6. Allikmets R., Shroyer N.F., Singh N., et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 277 (1997) 1805-1807
7. Klaver C.C., Kliffen M., van Duijn C.M., et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 63 (1998) 200-206
8. Schmidt S., Saunders A.M., De La Paz M.A., et al. Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. Mol Vis 6 (2000) 287-293
9. Hamdi H.K., Reznik J., Castellon R., et al. Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration. Biochem Biophys Res Commun 295 (2002) 668-672
10. Stone E.M., Braun T.A., Russell S.R., et al. Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 351 (2004) 346-353
11. Kimura K., Isashiki Y., Sonoda S., et al. Genetic association of manganese superoxide dismutase with exudative age-related macular degeneration. Am J Ophthalmol 130 (2000) 769-773
12. Fiotti N., Pedio M., Battaglia Parodi M., et al. MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration. Genet Med 7 (2005) 272-277
13. Esparza-Gordillo J., Soria J.M., Buil A., et al. Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics 56 (2004) 77-82
14. Muller-Eberhard H.J., and Schreiber R.D. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol 29 (1980) 1-53
15. Mullins R.F., Russell S.R., Anderson D.H., and Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14 (2000) 835-846
16. Johnson L.V., Leitner W.P., Staples M.K., and Anderson D.H. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 73 (2001) 887-896
17. Seddon J.M., Gensler G., Milton R.C., et al. Association between C-reactive protein and age-related macular degeneration. JAMA 291 (2004) 704-710
18. Gurne D.H., Tso M.O., Edward D.P., and Ripps H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 98 (1991) 602-607
19. Bird A.C., Bressler N.M., Bressler S.B., et al., The International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39 (1995) 367-374
20. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
21. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102 (2005) 7227-7232
22. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41 (2004) 355-367
23. Kew R.R., Ghebrehiwet B., and Janoff A. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest 75 (1985) 1000-1007
24. Zareparsi S., Branham K.E., Li M., et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77 (2005) 149-153
25. Postel E.A., Agarwal A., Caldwell J., et al. Complement factor H increases risk for atrophic age-related macular degeneration. Ophthalmology 113 (2006) 1504-1507
26. Sepp T., Khan J.C., Thurlby D.A., et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 47 (2006) 536-540